Pharmaceutical Technology
DECEMBER 22, 2022
Blueprint Medicines wins the Financing award this year after securing significant financing partnerships worth up to $1.25bn. Be Bio Blueprint Medicines Endeavor BioMedicines Kallyope Metagenomi Mineralys Neuron23 Nutcracker RayzeBio Rivus Ventus Therapeutics. Innovation. Civica JAAQ Sanofi.
The Pharma Data
DECEMBER 17, 2020
7, 2020 — After starting a drug that’s officially approved to treat a type of blood cancer, a young man with type 1 diabetes was able to stop using insulin. He’s been off insulin since August 2018 — more than two years. WEDNESDAY, Oct. It’s in a class of medications known as JAK inhibitors.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
SEPTEMBER 1, 2020
Similarly, whilst GlaxoSmithKline’s origins can be traced back as far as 1715, it was only in the middle of the 19th century that Beecham became involved in the industrial production of medicine, producing patented medicine from 1842, and the world’s first factory for producing only medicines in 1859.
Drug Discovery World
NOVEMBER 14, 2022
Alternative to insulin. A collaboration between PerkinElmer’s SIRION Biotech business and the Centre for Genomic Regulation (CRG) agreed to jointly develop new generation adeno-associated virus (AAV) vectors for type 1 and type 2 diabetes gene therapy in the pancreas. . AAV vectors for diabetes gene therapy.
The Pharma Data
DECEMBER 31, 2020
Researchers at Stanford Medicine found that COVID-19 antibodies preferentially target different parts of the SARS-CoV-2 virus in mild COVID-19 cases than they do in severe cases. Rhesus Macaque Genome Reference Includes 85 Million Genetic Variants. Every week there are numerous scientific studies published.
Drug Discovery World
SEPTEMBER 6, 2022
This area of medicine, which turns our own bodies into agents of combat to fight disease, has quickly become one of the most promising fields in treating deadly diseases such as cancer, central nervous system disorders and even musculoskeletal conditions. . billion, compared to $19.9 million price point per dose. Cancer is king .
The Pharma Data
JULY 23, 2021
The goal of the company’s cancer research is to deliver medicines that offer each patient a better, healthier life and to make cure a possibility. 1%) as determined by an FDA-approved test, with no EGFR or ALK genomic tumor aberrations.
Expert insights. Personalized for you.
130 
Let's personalize your content